Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Sinovac Biotech Current Ratio 2006-2018 | SVA

Sinovac Biotech current ratio from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Sinovac Biotech Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $0.21B $0.08B 2.54
2016-12-31 $0.13B $0.07B 1.97
2016-09-30 $0.13B $0.07B 1.91
2016-06-30 $0.11B $0.05B 2.11
2016-03-31 $0.13B $0.06B 2.21
2015-12-31 $0.13B $0.06B 2.21
2015-09-30 $0.12B $0.05B 2.44
2015-06-30 $0.14B $0.06B 2.24
2015-03-31 $0.13B $0.06B 2.20
2014-12-31 $0.16B $0.08B 1.94
2014-09-30 $0.16B $0.07B 2.19
2014-06-30 $0.15B $0.07B 2.28
2014-03-31 $0.16B $0.06B 2.47
2013-12-31 $0.16B $0.05B 3.20
2013-09-30 $0.15B $0.05B 2.87
2013-06-30 $0.14B $0.03B 4.21
2013-03-31 $0.13B $0.03B 3.99
2012-12-31 $0.13B $0.03B 4.19
2012-09-30 $0.12B $0.04B 3.00
2012-06-30 $0.12B $0.04B 3.29
2012-03-31 $0.12B $0.04B 3.52
2011-12-31 $0.13B $0.04B 3.25
2011-09-30 $0.13B $0.04B 3.67
2011-06-30 $0.13B $0.03B 3.86
2011-03-31 $0.14B $0.04B 3.13
2010-12-31 $0.15B $0.05B 3.22
2010-09-30 $0.15B $0.03B 5.51
2010-06-30 $0.15B $0.03B 6.16
2010-03-31 $0.17B $0.04B 4.12
2009-12-31 $0.12B $0.05B 2.37
2009-09-30 $0.10B $0.04B 2.39
2009-06-30 $0.09B $0.04B 2.47
2009-03-31 $0.06B $0.02B 3.00
2008-12-31 $0.06B $0.02B 2.93
2008-09-30 $0.06B $0.02B 3.23
2008-06-30 $0.06B $0.02B 2.55
2008-03-31 $0.05B $0.02B 2.57
2007-12-31 $0.04B $0.02B 1.92
2007-09-30 $0.04B $0.02B 1.75
2006-12-31 $0.02B $0.01B 1.83
2005-12-31 $0.02B $0.01B 1.84
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.421B $0.174B
Sonovac Biotech Ltd. specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza, `SARS`, and avian flu. Sinovac is one of the leading emerging biotechnology companies in China.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $123.735B 13.99
Gilead Sciences (GILD) United States $89.518B 10.78
Biogen (BIIB) United States $65.290B 13.22
Celgene (CELG) United States $48.703B 9.45
Illumina (ILMN) United States $47.030B 54.78
Vertex Pharmaceuticals (VRTX) United States $42.195B 73.71
Regeneron Pharmaceuticals (REGN) United States $37.368B 18.93
Alexion Pharmaceuticals (ALXN) United States $26.464B 18.11
BioMarin Pharmaceutical (BMRN) United States $17.041B 0.00
Incyte (INCY) United States $14.154B 391.23
Seattle Genetics (SGEN) United States $9.197B 0.00
Exact Sciences (EXAS) United States $8.773B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.028B 51.33
Sarepta Therapeutics (SRPT) United States $7.955B 0.00
QIAGEN (QGEN) Netherlands $7.897B 25.25
Alnylam Pharmaceuticals (ALNY) United States $7.391B 0.00
Bluebird Bio (BLUE) United States $6.855B 0.00
BeiGene (BGNE) Cayman Islands $6.829B 0.00
Bio-Techne Corp (TECH) United States $6.051B 40.88
Galapagos (GLPG) Belgium $5.361B 0.00
Alkermes (ALKS) Ireland $5.359B 3449.00
Exelixis (EXEL) United States $5.358B 15.19
Amarin (AMRN) Ireland $5.306B 0.00
Immunomedics (IMMU) United States $3.692B 0.00
Horizon Pharma Public (HZNP) Ireland $3.664B 15.08
Emergent Biosolutions (EBS) United States $3.631B 30.59
MorphoSys AG Unsponsored ADR (MOR) Germany $3.603B 0.00
Array BioPharma (ARRY) United States $3.490B 0.00
Ligand Pharmaceuticals (LGND) United States $3.283B 25.11
Allogene Therapeutics (ALLO) United States $3.224B 0.00
Guardant Health (GH) United States $3.113B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.046B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.999B 0.00
Repligen (RGEN) United States $2.871B 89.66
Genomic Health (GHDX) United States $2.753B 92.93
Ultragenyx Pharmaceutical (RARE) United States $2.694B 0.00
Akcea Therapeutics (AKCA) United States $2.675B 0.00
Ascendis Pharma (ASND) Denmark $2.497B 0.00
Allakos (ALLK) United States $2.484B 0.00
China Biologic Products (CBPO) China $2.467B 17.56
Blueprint Medicines (BPMC) United States $2.425B 0.00
Acceleron Pharma (XLRN) United States $2.413B 0.00
MyoKardia (MYOK) United States $2.384B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.368B 0.00
Myriad Genetics (MYGN) United States $2.348B 23.27
Halozyme Therapeutics (HALO) United States $2.332B 52.03
REGENXBIO (RGNX) United States $2.319B 31.11
Arena Pharmaceuticals (ARNA) United States $2.059B 0.00
Amicus Therapeutics (FOLD) United States $2.035B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.928B 0.00
Global Blood Therapeutics (GBT) United States $1.897B 0.00
AnaptysBio (ANAB) United States $1.835B 0.00
Denali Therapeutics (DNLI) United States $1.826B 0.00
Reata Pharmaceuticals (RETA) United States $1.779B 0.00
Aimmune Therapeutics (AIMT) United States $1.740B 0.00
Atara Biotherapeutics (ATRA) United States $1.702B 0.00
Innoviva (INVA) United States $1.651B 9.34
Rubius Therapeutics (RUBY) United States $1.599B 0.00
Cambrex (CBM) United States $1.587B 11.85
ORCHARD THERAPT (ORTX) United Kingdom $1.572B 0.00
G1 THERAPEUTICS (GTHX) United States $1.538B 0.00
NeoGenomics (NEO) United States $1.499B 123.92
Medicines (MDCO) United States $1.485B 0.00
Spark Therapeutics (ONCE) United States $1.479B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.408B 0.00
Editas Medicine (EDIT) United States $1.385B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.373B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.357B 0.00
Insmed (INSM) United States $1.331B 0.00
Mirati Therapeutics (MRTX) United States $1.331B 0.00
Myovant Sciences (MYOV) United Kingdom $1.329B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.253B 99.50
Solid Biosciences (SLDB) United States $1.199B 0.00
UniQure (QURE) Netherlands $1.187B 0.00
WAVE Life Sciences (WVE) Singapore $1.186B 0.00
Lion Biotechnologies (IOVA) United States $1.180B 0.00
Sangamo Therapeutics (SGMO) United States $1.144B 0.00
IMMURON LTD (IMRN) Australia $1.128B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.045B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.039B 0.00
Retrophin (RTRX) United States $1.038B 0.00
Audentes Therapeutics (BOLD) United States $1.004B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.988B 0.00
DBV Technologies (DBVT) France $0.951B 0.00
Acorda Therapeutics (ACOR) United States $0.941B 11.92
Lexicon Pharmaceuticals (LXRX) United States $0.924B 0.00
Cellectis (CLLS) France $0.915B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.907B 0.00
Puma Biotechnology (PBYI) United States $0.899B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.888B 0.00
Clovis Oncology (CLVS) United States $0.883B 0.00
Intra-Cellular Therapies (ITCI) United States $0.868B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.864B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.857B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.850B 0.00
Apellis Pharmaceuticals (APLS) United States $0.849B 0.00
Coherus BioSciences (CHRS) United States $0.835B 0.00
Viking Therapeutics (VKTX) United States $0.832B 0.00
Fate Therapeutics (FATE) United States $0.819B 0.00
Athenex (ATNX) United States $0.801B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.791B 0.00
Aptinyx (APTX) United States $0.784B 0.00
Revance Therapeutics (RVNC) United States $0.776B 0.00
Intellia Therapeutics (NTLA) United States $0.775B 0.00
Heska (HSKA) United States $0.770B 63.00
Dynavax Technologies (DVAX) United States $0.769B 0.00
Cara Therapeutics (CARA) United States $0.748B 0.00
TWIST BIOSCIENC (TWST) United States $0.748B 0.00
Vericel (VCEL) United States $0.736B 0.00
Novavax (NVAX) United States $0.697B 0.00
Gritstone Oncology (GRTS) United States $0.668B 0.00
InflaRx (IFRX) Germany $0.655B 0.00
CytomX Therapeutics (CTMX) United States $0.651B 0.00
UROGEN PHARMA (URGN) Israel $0.648B 0.00
AVROBIO (AVRO) United States $0.644B 0.00
AC Immune SA (ACIU) Switzerland $0.643B 0.00
ANI Pharmaceuticals (ANIP) United States $0.628B 12.00
Epizyme (EPZM) United States $0.627B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.621B 0.00
Senesco Technologies (ELOX) United States $0.611B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.608B 0.00
Principia Biopharma (PRNB) United States $0.606B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.568B 0.00
RA PHARMCTL INC (RARX) United States $0.541B 0.00
Arvinas (ARVN) United States $0.532B 0.00
UNITY Biotechnology (UBX) $0.520B 0.00
Eidos Therapeutics (EIDX) United States $0.519B 0.00
Arcus Biosciences (RCUS) United States $0.518B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.513B 0.00
Anika Therapeutics (ANIK) United States $0.507B 21.01
Scholar Rock Holding (SRRK) United States $0.506B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.498B 0.00
Kezar Life Sciences (KZR) United States $0.495B 0.00
Inovio Pharmaceuticals (INO) United States $0.488B 0.00
Mesoblast (MESO) Australia $0.480B 0.00
BeyondSpring (BYSI) United States $0.478B 0.00
Kura Oncology (KURA) United States $0.471B 0.00
ObsEva SA (OBSV) Switzerland $0.470B 0.00
Prothena (PRTA) Ireland $0.465B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.456B 0.00
Sorrento Therapeutics (SRNE) United States $0.454B 74.20
Replimune (REPL) United States $0.443B 0.00
PDL BioPharma (PDLI) United States $0.439B 7.17
Kindred Biosciences (KIN) United States $0.437B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.423B 0.00
Five Prime Therapeutics (FPRX) United States $0.421B 0.00
MediciNova (MNOV) United States $0.413B 0.00
Zymeworks (ZYME) Canada $0.410B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.399B 0.00
Verastem (VSTM) United States $0.399B 0.00
Abeona Therapeutics (ABEO) United States $0.396B 0.00
Zealand Pharma (ZEAL) Denmark $0.376B 4.15
Cytokineticsorporated (CYTK) United States $0.369B 0.00
ResTORbio (TORC) United States $0.369B 0.00
Stemline Therapeutics (STML) United States $0.362B 0.00
Osiris Therapeutics (OSIR) United States $0.357B 0.00
MeiraGTx Holdings (MGTX) United States $0.351B 0.00
Kodiak Sciences (KOD) United States $0.350B 0.00
Liquidia Technologies (LQDA) United States $0.345B 0.00
Seres Therapeutics (MCRB) United States $0.335B 0.00
Cellular Biomedicine (CBMG) United States $0.319B 0.00
Merus (MRUS) Netherlands $0.318B 0.00
Albireo Pharma (ALBO) United States $0.316B 0.00
LogicBio Therapeutics (LOGC) United States $0.311B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.303B 0.00
Krystal Biotech (KRYS) United States $0.299B 0.00
Kadmon Holdings (KDMN) United States $0.296B 0.00
Geron (GERN) United States $0.296B 0.00
Equillium (EQ) United States $0.294B 0.00
MannKind (MNKD) United States $0.287B 0.00
Sutro Biopharma (STRO) United States $0.285B 0.00
Athersys (ATHX) United States $0.285B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.280B 0.00
Syros Pharmaceuticals (SYRS) United States $0.275B 0.00
BioDelivery Sciences (BDSI) United States $0.269B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.268B 0.00
Celyad SA (CYAD) Belgium $0.267B 0.00
Celcuity (CELC) United States $0.264B 0.00
Evelo Biosciences (EVLO) United States $0.263B 0.00
Arbutus Biopharma (ABUS) Canada $0.261B 0.00
Aduro Biotech (ADRO) United States $0.260B 0.00
Magenta Therapeutics (MGTA) United States $0.258B 0.00
Agenus (AGEN) United States $0.253B 0.00
TOCAGEN INC (TOCA) United States $0.247B 0.00
Axovant Sciences (AXON) United Kingdom $0.245B 0.00
Synlogic (SYBX) United States $0.243B 0.00
Unum Therapeutics (UMRX) United States $0.242B 0.00
Adverum Biotechnologies (ADVM) United States $0.240B 0.00
ADMA Biologics Inc (ADMA) United States $0.239B 0.00
Strongbridge Biopharma (SBBP) United States $0.238B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.237B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.237B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.233B 0.00
Urovant Sciences (UROV) United States $0.227B 0.00
Proteostasis Therapeutics (PTI) United States $0.225B 0.00
Kala Pharmaceuticals (KALA) United States $0.224B 0.00
Kamada (KMDA) Israel $0.214B 19.70
Xenon Pharmaceuticals (XENE) Canada $0.214B 0.00
Protagonist Therapeutics (PTGX) United States $0.212B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.210B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.204B 0.00
Idera Pharmaceuticals (IDRA) United States $0.203B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.199B 0.00
Intec Pharma (NTEC) Israel $0.195B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.193B 0.00
ChromaDex (CDXC) United States $0.192B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.188B 0.00
NantKwest (NK) United States $0.181B 0.00
Allena Pharmaceuticals (ALNA) United States $0.179B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.176B 0.00
Compugen (CGEN) Israel $0.170B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.165B 0.00
Menlo Therapeutics (MNLO) United States $0.162B 0.00
PSivida (EYPT) United States $0.162B 0.00
Cerecor (CERC) United States $0.153B 0.00
XBiotech (XBIT) United States $0.148B 0.00
Constellation Pharmaceuticals (CNST) United States $0.148B 0.00
Mersana Therapeutics (MRSN) United States $0.146B 0.00
Enzo Biochem (ENZ) United States $0.145B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.145B 0.00
Spero Therapeutics (SPRO) United States $0.141B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.137B 0.00
Cohbar (CWBR) United States $0.134B 0.00
Selecta Biosciences (SELB) United States $0.134B 0.00
Eleven Biotherapeutics (SESN) United States $0.132B 0.00
Catalyst Biosciences (CBIO) United States $0.131B 0.00
Pluristem Therapeutics (PSTI) Israel $0.127B 0.00
Applied Genetic Technologies (AGTC) United States $0.124B 0.00
Organovo Holdings (ONVO) United States $0.123B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.122B 0.00
XOMA (XOMA) United States $0.120B 0.00
Mustang Bio (MBIO) United States $0.116B 0.00
VBI Vaccines (VBIV) United States $0.115B 0.00
Motif Bio Plc (MTFB) United States $0.114B 0.00
OVID THERAPEUTC (OVID) United States $0.113B 0.00
Cue Biopharma (CUE) United States $0.112B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.111B 0.00
Anavex Life Sciences (AVXL) United States $0.110B 0.00
Cidara Therapeutics (CDTX) United States $0.108B 0.00
Signal Genetics (MGEN) United States $0.107B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.102B 0.00
Chiasma (CHMA) United States $0.094B 0.00
Provention Bio (PRVB) United States $0.094B 0.00
Neothetics (EVFM) United States $0.091B 0.00
BioXcel Therapeutics (BTAI) United States $0.090B 0.00
Orgenesis (ORGS) United States $0.088B 0.00
Aptose Biosciences (APTO) Canada $0.087B 0.00
Cocrystal Pharma (COCP) United States $0.085B 94.77
Axsome Therapeutics (AXSM) United States $0.084B 0.00
Checkpoint Therapeutics (CKPT) United States $0.081B 0.00
Ophthotech (OPHT) United States $0.080B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.079B 0.00
ScPharmaceuticals (SCPH) United States $0.076B 0.00
VTv Therapeutics (VTVT) United States $0.075B 0.00
PHASEBIO PHARMA (PHAS) United States $0.075B 0.00
ITUS (ANIX) United States $0.075B 0.00
Monster Digital (INNT) United States $0.074B 0.00
Alcobra (ARCT) United States $0.073B 0.00
Prima BioMed (IMMP) Australia $0.073B 0.00
Vaccinex (VCNX) United States $0.073B 0.00
Bionano Genomics (BNGO) United States $0.072B 0.00
Alimera Sciences (ALIM) United States $0.071B 0.00
NewLink Genetics (NLNK) United States $0.070B 0.00
Fortress Biotech (FBIO) United States $0.070B 0.00
Evogene (EVGN) Israel $0.069B 0.00
Versartis (ARAV) United States $0.067B 5.89
Brainstorm Cell Therapeutics (BCLI) United States $0.065B 0.00
Aptevo Therapeutics (APVO) United States $0.065B 0.00
Entera Bio (ENTX) Israel $0.061B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.060B 0.00
Sophiris Bio (SPHS) United States $0.059B 0.00
Celldex Therapeutics (CLDX) United States $0.057B 0.00
Leap Therapeutics (LPTX) United States $0.056B 0.00
VistaGen Therapeutics (VTGN) United States $0.056B 0.00
Bellerophon Therapeutics (BLPH) United States $0.056B 0.00
Trevena (TRVN) United States $0.053B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.053B 8.50
Oncobiologics (ONS) United States $0.052B 0.00
Clearside Biomedical (CLSD) United States $0.052B 0.00
Curis (CRIS) United States $0.049B 0.00
OncoSec Medical (ONCS) United States $0.048B 0.00
AEterna Zentaris (AEZS) United States $0.048B 9.06
Caladrius Biosciences (CLBS) United States $0.047B 0.00
Zosano Pharma (ZSAN) United States $0.046B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.046B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.044B 0.00
Oncolytics Biotech (ONCY) Canada $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.039B 0.00
TRACON Pharmaceuticals (TCON) United States $0.039B 0.00
AZURRX BIOPHARM (AZRX) United States $0.038B 0.00
Moleculin Biotech (MBRX) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.038B 0.00
Galena Biopharma (SLS) United States $0.036B 0.00
GTx (GTXI) United States $0.036B 0.00
AquaBounty Technologies (AQB) United States $0.036B 0.00
Celsion (CLSN) United States $0.036B 0.00
VIVUS (VVUS) United States $0.034B 0.00
Aileron Therapeutics (ALRN) United States $0.032B 0.00
Proteon Therapeutics (PRTO) United States $0.031B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
Therapix Biosciences (TRPX) Israel $0.030B 11.23
Histogenics (HSGX) United States $0.028B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.027B 0.00
Vical (VICL) United States $0.027B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Benitec Biopharma (BNTC) Australia $0.025B 0.00
OvaScience (OVAS) United States $0.024B 0.00
Cellect Biotechnology (APOP) Israel $0.023B 0.00
Edge Therapeutics (EDGE) United States $0.022B 0.00
GENPREX INC (GNPX) United States $0.021B 0.00
CytRx (CYTR) United States $0.020B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Pulmatrix (PULM) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Novelion Therapeutics (NVLN) Canada $0.019B 0.00
Arsanis (ASNS) United States $0.018B 0.00
Soligenix (SNGX) United States $0.018B 0.00
TrovaGene (TROV) United States $0.017B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Adial Pharmaceuticals (ADIL) United States $0.009B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Alliqua BioMedical (ALQA) United States $0.008B 0.00
Aytu Bioscience (AYTU) United States $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00